Literature DB >> 15618167

Downregulation of mitogen-activated protein kinases by the Bordetella bronchiseptica Type III secretion system leads to attenuated nonclassical macrophage activation.

Annette Reissinger1, Jason A Skinner, Ming H Yuk.   

Abstract

Bordetella bronchiseptica utilizes a type III secretion system (TTSS) to establish a persistent infection of the murine respiratory tract. Previous studies have shown that the Bordetella TTSS mediated cytotoxicity in different cell types, inhibition of NF-kappaB in epithelial cells, and differentiation of dendritic cells into a semimature state. Here we demonstrate modulation of mitogen-activated protein kinase (MAPK) signaling pathways and altered cytokine production in macrophages and dendritic cells by the Bordetella TTSS. In macrophages, the MAPKs ERK and p38 were downregulated. This resulted in attenuated production of interleukin- (IL-)6 and IL-10. In contrast, the Th-1-polarizing cytokine IL-12 was produced at very low levels and remained unmodulated by the Bordetella TTSS. In dendritic cells, ERK was transiently activated, but this failed to alter cytokine profiles. These results suggest that the Bordetella TTSS modulates antigen-presenting cells in a cell type-specific manner and the secretion of high levels of IL-6 and IL-10 by macrophages might be important for pathogen clearance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15618167      PMCID: PMC538969          DOI: 10.1128/IAI.73.1.308-316.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

Review 1.  Mammalian MAP kinase signalling cascades.

Authors:  L Chang; M Karin
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

Review 2.  Yersinia effectors target mammalian signalling pathways.

Authors:  Stephen J Juris; Feng Shao; Jack E Dixon
Journal:  Cell Microbiol       Date:  2002-04       Impact factor: 3.715

Review 3.  MAP kinases in the immune response.

Authors:  Chen Dong; Roger J Davis; Richard A Flavell
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 4.  Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.

Authors:  C M Tato; C A Hunter
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

5.  Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?

Authors:  Manfred B Lutz; Gerold Schuler
Journal:  Trends Immunol       Date:  2002-09       Impact factor: 16.687

6.  Pseudomonas aeruginosa-induced apoptosis involves mitochondria and stress-activated protein kinases.

Authors:  V Jendrossek; H Grassmé; I Mueller; F Lang; E Gulbins
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  Role of Bordetella bronchiseptica fimbriae in tracheal colonization and development of a humoral immune response.

Authors:  S Mattoo; J F Miller; P A Cotter
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

8.  Yersinia enterocolitica can deliver Yop proteins into a wide range of cell types: development of a delivery system for heterologous proteins.

Authors:  A P Boyd; N Grosdent; S Tötemeyer; C Geuijen; S Bleves; M Iriarte; I Lambermont; J N Octave; G R Cornelis
Journal:  Eur J Cell Biol       Date:  2000-10       Impact factor: 4.492

Review 9.  Phagocytosis of bacterial pathogens: implications in the host response.

Authors:  P Sansonetti
Journal:  Semin Immunol       Date:  2001-12       Impact factor: 11.130

10.  A novel phenotype for an activated macrophage: the type 2 activated macrophage.

Authors:  Charles F Anderson; David M Mosser
Journal:  J Leukoc Biol       Date:  2002-07       Impact factor: 4.962

View more
  9 in total

1.  Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.

Authors:  Neil K Fennelly; Federico Sisti; Sarah C Higgins; Pádraig J Ross; Han van der Heide; Frits R Mooi; Aoife Boyd; Kingston H G Mills
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

2.  Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection.

Authors:  Paul B Mann; Daniel Wolfe; Eicke Latz; Douglas Golenbock; Andrew Preston; Eric T Harvill
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence.

Authors:  Daniel V Zurawski; Chieko Mitsuhata; Karen L Mumy; Beth A McCormick; Anthony T Maurelli
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

4.  Bordetella bronchiseptica flagellin is a proinflammatory determinant for airway epithelial cells.

Authors:  Yolanda S López-Boado; Laura M Cobb; Rajendar Deora
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

5.  The Vibrio parahaemolyticus Type III Secretion Systems manipulate host cell MAPK for critical steps in pathogenesis.

Authors:  Ksenia Matlawska-Wasowska; Rebecca Finn; Ana Mustel; Conor P O'Byrne; Alan W Baird; Eleanor T Coffey; Aoife Boyd
Journal:  BMC Microbiol       Date:  2010-12-30       Impact factor: 3.605

6.  Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN.

Authors:  Kanna Nagamatsu; Asaomi Kuwae; Tadashi Konaka; Shigenori Nagai; Sei Yoshida; Masahiro Eguchi; Mineo Watanabe; Hitomi Mimuro; Shigeo Koyasu; Akio Abe
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

7.  In vivo colonization profile study of Bordetella bronchiseptica in the nasal cavity.

Authors:  Yasuhiko Irie; Ming H Yuk
Journal:  FEMS Microbiol Lett       Date:  2007-08-22       Impact factor: 2.742

8.  Respiratory Bordetella bronchiseptica Carriage is Associated with Broad Phenotypic Alterations of Peripheral CD4⁺CD25⁺ T Cells and Differentially Affects Immune Responses to Secondary Non-Infectious and Infectious Stimuli in Mice.

Authors:  Andreas Jeron; Julia D Boehme; Julia Volckmar; Marcus Gereke; Tetyana Yevsa; Robert Geffers; Carlos A Guzmán; Jens Schreiber; Sabine Stegemann-Koniszewski; Dunja Bruder
Journal:  Int J Mol Sci       Date:  2018-09-01       Impact factor: 5.923

Review 9.  Bordetella Type III Secretion Injectosome and Effector Proteins.

Authors:  Jana Kamanova
Journal:  Front Cell Infect Microbiol       Date:  2020-09-04       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.